Opening book details…
About this book
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial by Othman Al-Sawaf & Rudy Ligtvoet & Sandra Robrecht & Janina Stumpf & Anna-Maria Fink & Eugen Tausch & Christof Schneider & Sebastian Boettcher & Martin Mikusko & Matthias Ritgen & Johannes Schetelig & Julia Tresckow & Ursula Vehling-Kaiser & Tobias... is a book available to read on EtoBox.
- Author
- Othman Al-Sawaf & Rudy Ligtvoet & Sandra Robrecht & Janina Stumpf & Anna-Maria Fink & Eugen Tausch & Christof Schneider & Sebastian Boettcher & Martin Mikusko & Matthias Ritgen & Johannes Schetelig & Julia Tresckow & Ursula Vehling-Kaiser & Tobias...
- Publisher
- Springer US
- Published
- 2024
- Language
- EN
More by Othman Al-Sawaf & Rudy Ligtvoet & Sandra Robrecht & Janina Stumpf & Anna-Maria Fink & Eugen Tausch & Christof Schneider & Sebastian Boettcher & Martin Mikusko & Matthias Ritgen & Johannes Schetelig & Julia Tresckow & Ursula Vehling-Kaiser & Tobias...
Similar books
- Elranatamab in Relapsed or Refractory Multiple Myeloma: Phase 2 MagnetisMM-3 Trial Results — Alexander M. Lesokhin & Michael H. Tomasson & Bertrand Arnulf & Nizar J. Bahlis & H. Miles Prince & Ruben Niesvizky & Paula Rodrίguez-Otero & Joaquin Martinez-Lopez & Guenther Koehne & Cyrille Touzeau & Yogesh Jethava & Hang Quach & Julien Depaus &... (2023)
- Dabrafenib Plus Trametinib in BRAFV600E-mutated Rare Cancers: the Phase 2 ROAR Trial — Vivek Subbiah & Robert J. Kreitman & Zev A. Wainberg & Anas Gazzah & Ulrik Lassen & Alexander Stein & Patrick Y. Wen & Sascha Dietrich & Maja J. A. Jonge & Jean-Yves Blay & Antoine Italiano & Kan Yonemori & Daniel C. Cho & Filip Y. F. L. Vos & Philippe... (2023)
- Nivolumab Plus Ipilimumab in Advanced Salivary Gland Cancer: a Phase 2 Trial — Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &... (2023)
- Neoadjuvant Atezolizumab Plus Chemotherapy in Gastric and Gastroesophageal Junction Adenocarcinoma: the Phase 2 PANDA Trial — Yara L. Verschoor & Joris Haar & José G. Berg & Johanna W. Sandick & Liudmila L. Kodach & Jolanda M. Dieren & Sara Balduzzi & Cecile Grootscholten & Marieke E. IJsselsteijn & Alexander A. F. A. Veenhof & Koen J. Hartemink & Marieke A. Vollebergh &... (2024)
- Oncolytic DNX-2401 Virotherapy Plus Pembrolizumab in Recurrent Glioblastoma: a Phase 1/2 Trial — Farshad Nassiri & Vikas Patil & Leeor S. Yefet & Olivia Singh & Jeff Liu & Rachel M. A. Dang & Takafumi N. Yamaguchi & Mariza Daras & Timothy F. Cloughesy & Howard Colman & Priya U. Kumthekar & Clark C. Chen & Robert Aiken & Morris D. Groves & Shirley... (2023)
- Gemcitabine and Cisplatin Plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: a Phase 2 Trial — Matthew D. Galsky & Siamak Daneshmand & Sudeh Izadmehr & Edgar Gonzalez-Kozlova & Kevin G. Chan & Sara Lewis & Bassam El Achkar & Tanya B. Dorff & Jeremy Paul Cetnar & Brock O. Neil & Anishka Damp#x02019; Souza & Ronac Mamtani & Christos Kyriakopoulos &... (2024)